View Cart (0 items)

Items Tagged with 'glaxosmithkline'


GlaxoSmithKline plans stock market sale of minority stake in HIV treatment company

British pharmaceutical group GlaxoSmithKline plc (GSK) is planning to spin off a subsidiary that focuses on developing treatments for HIV.
Read More

GSK recalls batches of Eye-Mo solution

London-listed pharmaceuticals giant GlaxoSmithKline (GSK) has launched a voluntary recall of several batches of its Eye-Mo Red Eyes Formula Ophthalmic Solution.
Read More

GSK to start clinical trials on new Ebola vaccine

London-listed pharmaceuticals company GlaxoKlineSmith will start clinical safety trials for its experimental Ebola vaccine in the U.S. as early as next week.
Read More

GlaxoSmithKline sets up $50 million fund to develop bioelectronic medicines

UK-based GlaxoSmithKline, one of the biggest pharmaceutical companies on the planet, wants to be a leader in the bioelectronic medicines space.
Read More

Chinese pharma probe spreads to two Danish drug makers

Western pharmaceutical companies are coming under increased scrutiny in China following the bribery accusations leveled last month against GlaxoSmithKline (GSK).
Read More

Engineer suffers chemical burns at GlaxoSmithKline plant

A 20-year-old engineer suffered chemical burns Tuesday in an industrial accident at a GlaxoSmithKline (GSK) plant.
Read More

Asia offers big business opportunities to pharma companies

Asia is emerging as a strategically important location for global pharmaceutical companies that are looking to take advantage of the opportunities available in terms of R&D, manufacturing and market.
Read More

Pharma companies set high hopes for 2013

Following the approval of 39 new drugs in 2012, and with a number of new pharmaceutical products already in their final stages of development, global pharma companies are optimistic about the next 12 months.
Read More